TASK A30: In vitro screening for antibacterial activity against biodefense and emerging infectious disease pathogens

任务 A30：针对生物防御和新出现的传染病病原体的抗菌活性的体外筛选

• 批准号: 9566531
• 负责人: RICHARD SLAYDEN
• 金额: $ 8.16万
• 依托单位: COLORADO STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-09-13 至 2018-09-12
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9566531
• 关键词: Advanced Development; Anti-Bacterial Agents; Antifungal Agents; Biological Assay; Contracts; Development; Emerging Communicable Diseases; In Vitro; Maintenance; Therapeutic; biodefense; in vitro testing; pathogen; screening

This contract provides in vitro testing of potential anti-bacterial and anti-fungal agents, maintenance of bacterial and fungal stocks, and the development of related assays.

该合同提供潜在抗菌和抗真菌剂的体外测试、细菌和真菌库存的维护以及相关测定的开发。